ABL2 |
ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 |
SLA2 |
SLA2, C20orf156, SLAP2: Src-like-adapter 2 |
1.132 |
Evidence |
|
GNAI3 |
GNAI3: Guanine nucleotide-binding protein G(k) subunit alpha |
DRD2 |
DRD2: D(2) dopamine receptor |
1.132 |
Evidence |
|
EDAR |
EDAR, DL: Tumor necrosis factor receptor superfamily member EDAR precursor |
TNFSF13B |
TNFSF13B, BAFF, UNQ401/PRO738, BLYS, TALL1, TNFSF20, ZTNF4: Tumor necrosis facto |
1.132 |
Evidence |
|
GNA14 |
GNA14: Guanine nucleotide-binding protein alpha-14 subunit |
C3AR1 |
C3AR1, AZ3B, C3R1, HNFAG09: C3a anaphylatoxin chemotactic receptor |
1.132 |
Evidence |
|
BMX |
IPI00514142 |
GRB2 |
GRB2, ASH: Growth factor receptor-bound protein 2 |
1.132 |
Evidence |
|
FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
MATK |
MATK, CTK, HYL: Megakaryocyte-associated tyrosine-protein kinase |
1.132 |
Evidence |
|
GNA15 |
GNA15, GNA16: Guanine nucleotide-binding protein alpha-15 subunit |
EDNRB |
EDNRB, ETRB: Endothelin B receptor precursor |
1.132 |
Evidence |
|
CSH2 |
GH1: Somatotropin precursor |
IL4R |
IL4R, 582J2.1, IL4RA: Interleukin-4 receptor alpha chain precursor |
1.132 |
Evidence |
|
TFAP4 |
TFAP4: Transcription factor AP-4 |
ID3 |
ID3, 1R21, HEIR-1: DNA-binding protein inhibitor ID-3 |
1.132 |
Evidence |
|
LIF |
LIF, HILDA: Leukemia inhibitory factor precursor |
IL4R |
IL4R, 582J2.1, IL4RA: Interleukin-4 receptor alpha chain precursor |
1.132 |
Evidence |
|
MATK |
MATK, CTK, HYL: Megakaryocyte-associated tyrosine-protein kinase |
BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
1.132 |
Evidence |
|
HLA-A |
HLA-A, HLAA: HLA class I histocompatibility antigen, A-3 alpha chain precursor |
AZGP1 |
AZGP1, tcag7.638: Alpha-2-glycoprotein 1, zinc-binding |
1.132 |
Evidence |
|
PTK6 |
PTK6, BRK: Tyrosine-protein kinase 6 |
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
1.132 |
Evidence |
|
KITLG |
KITLG, MGF, SCF: Kit ligand precursor |
IL4R |
IL4R, 582J2.1, IL4RA: Interleukin-4 receptor alpha chain precursor |
1.132 |
Evidence |
|
APS |
SH2B2, APS: SH2B adapter protein 2 |
ABL2 |
ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 |
1.132 |
Evidence |
|
ABL2 |
ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 |
SH2D2A |
SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A |
1.132 |
Evidence |
|
NGFR |
NGFR, TNFRSF16: Tumor necrosis factor receptor superfamily member 16 precursor |
TNFSF13B |
TNFSF13B, BAFF, UNQ401/PRO738, BLYS, TALL1, TNFSF20, ZTNF4: Tumor necrosis facto |
1.132 |
Evidence |
|
TRPM7 |
TRPM7, CHAK1, LTRPC7: Transient receptor potential cation channel subfamily M me |
TRPV4 |
TRPV4, VRL2, VROAC: Transient receptor potential cation channel subfamily V memb |
1.132 |
Evidence |
|
DUSP1 |
DUSP1, CL100, MKP1, PTPN10, VH1: Dual specificity protein phosphatase 1 |
MAPK15 |
IPI00395861 |
1.132 |
Evidence |
|
RANGAP1 |
RANGAP1, SD: Ran GTPase-activating protein 1 |
CASP9 |
CASP9, MCH6: Caspase-9 precursor |
1.132 |
Evidence |
|
GNAO1 |
GNAO1: Guanine nucleotide-binding protein G(o) subunit alpha 1 |
F2R |
F2R, CF2R, PAR1, TR: Proteinase-activated receptor 1 precursor |
1.132 |
Evidence |
|
YES1 |
YES1, YES: Proto-oncogene tyrosine-protein kinase Yes |
SLA2 |
SLA2, C20orf156, SLAP2: Src-like-adapter 2 |
1.132 |
Evidence |
|
TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
SLA2 |
SLA2, C20orf156, SLAP2: Src-like-adapter 2 |
1.132 |
Evidence |
|
SERPINA1 |
SERPINA1, AAT, PRO0684, PI, PRO2209: Alpha-1-antitrypsin precursor |
KLK3 |
KLK3, APS: Prostate-specific antigen precursor |
1.132 |
Evidence |
|
GRB2 |
GRB2, ASH: Growth factor receptor-bound protein 2 |
TESK1 |
TESK1: Dual specificity testis-specific protein kinase 1 |
1.132 |
Evidence |
|